Naltrexone Augmentation of Nicotine Patch Therapy - 1

This study has been completed.

Sponsor:

Information provided by:

National Institute on Drug Abuse (NIDA)

ClinicalTrials.gov Identifier:

NCT00218153

First received: September 16, 2005

Last updated: November 3, 2005

Last verified: September 2005

History of Changes

Full Text View
Tabular View
No Study Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	April 2004
Estimated Primary Completion Date:	No date given

No publications provided by National Institute on Drug Abuse (NIDA)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

O'Malley SS, Krishnan-Sarin S, McKee SA, Leeman RF, Cooney NL, Meandzija B, Wu R, Makuch RW. Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation. Int J Neuropsychopharmacol. 2009 Jun;12(5):589-97. Epub 2008 Sep 17.

To Top